Login / Signup

The genomic landscape of pediatric acute lymphoblastic leukemia.

Samuel L BradyKathryn G RobertsZhaohui GuLei ShiStanley B PoundsDeqing PeiCheng ChengYunfeng DaiMeenakshi DevidasChunxu QuAshley N HillDebbie Payne-TurnerXiaotu MaIlaria IacobucciPradyuamna BaviskarLei WeiSasi ArunachalamKohei HagiwaraYanling LiuDiane A FlaschYu LiuMatthew D ParkerXiaolong ChenAbdelrahman H ElsayedOmkar PathakYongjin LiYiping FanJ Robert MichaelMichael C RuschMark R WilkinsonScott FoyDale J HedgesScott NewmanXin ZhouJian WangColleen ReillyEdgar SiosonStephen V RiceVictor Pastor LoyolaGang WuEvadnie RampersaudShalini C ReshmiJulie Gastier-FosterJaime M Guidry AuvilPatee GesuwanMalcolm A SmithNaomi J WinickAndrew J CarrollNyla A HeeremaRichard C HarveyCheryl L WillmanEric LarsenElizabeth A RaetzMichael J BorowitzBrent L WoodWilliam L CarrollPatrick A Zweidler-McKayKaren R RabinLeonard A MattanoKelly W MaloneyStuart S WinterMichael J BurkeWanda SalzerKimberly P DunsmoreAnne L AngiolilloKristine R CrewsJames R DowningSima JehaChing-Hong PuiWilliams E EvansJun J YangMary V RellingDaniela S GerhardMignon L LohStephen P HungerJinghui ZhangCharles G Mullighan
Published in: Nature genetics (2022)
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low mutation burden, ALL cases harbor a median of four putative somatic driver alterations per sample, with 376 putative driver genes identified varying in prevalence across ALL subtypes. Most samples harbor at least one rare gene alteration, including 70 putative cancer driver genes associated with ubiquitination, SUMOylation, noncoding transcripts and other functions. In hyperdiploid B-ALL, chromosomal gains are acquired early and synchronously before ultraviolet-induced mutation. By contrast, ultraviolet-induced mutations precede chromosomal gains in B-ALL cases with intrachromosomal amplification of chromosome 21. We also demonstrate the prognostic significance of genetic alterations within subtypes. Intriguingly, DUX4- and KMT2A-rearranged subtypes separate into CEBPA/FLT3- or NFATC4-expressing subgroups with potential clinical implications. Together, these results deepen understanding of the ALL genomic landscape and associated outcomes.
Keyphrases